Diclofenac Sodium and MisoprostolDelayed-Release (Eagle Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Diclofenac Sodium and Misoprostol drug offered from Eagle Pharmaceuticals, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eagle Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Diclofenac Sodium and Misoprostol |
SUBSTANCE NAME: | DICLOFENAC SODIUM; MISOPROSTOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Prostaglandin E1 Analog [EPC],Prostaglandins E, Synthetic [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-07-15 |
END MARKETING DATE: | 0000-00-00 |
Diclofenac Sodium and Misoprostol Delayed-Release HUMAN PRESCRIPTION DRUG Details:
Item Description | Diclofenac Sodium and Misoprostol Delayed-Release from Eagle Pharmaceuticals, Inc. |
LABELER NAME: | Eagle Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; .2(mg/1; mg/1) |
START MARKETING DATE: | 2014-07-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42367-110_a9cea5dd-d282-4ba2-ac44-d8b01eceffb1 |
PRODUCT NDC: | 42367-110 |
APPLICATION NUMBER: | ANDA200540 |
Other DICLOFENAC SODIUM; MISOPROSTOL Pharmaceutical Manufacturers / Labelers: